Purchase Order VA580N14711
Award Date 11/8/10
Potential Completion Date 12/8/10
Potential Value $3.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Scottsdale, AZ 85257, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company. The $7,055.10 firm-fixed-price purchase order is for the provision of the Provant Therapy System, a patented noninvasive regenerative medicine product developed by Regenesis Biomedical. The contract, which does not utilize any set-aside, is awarded against Regenesis Biomedical's GSA Schedule 65-II-A contract for medical equipment and supplies. The...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm-fixed-price purchase order is for the company's Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of May 8, 2011 and was awarded through Regenesis Biomedical's existing GSA Schedule...
- This federal contract award to Regenesis Biomedical Inc. is for the supply of the company's Provant Therapy System medical device and related rental/leasing services to the U.S. Department of Veterans Affairs (VA). The $4,882.79 firm-fixed-price purchase order was awarded on February 16, 2011, with a completion date of March 16, 2011. The contract was awarded against Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a private medical technology company, for the provision of the Provant Therapy System and related rental services. The $4,820.98 firm fixed-price purchase order contract was awarded on April 21, 2011, with a completion date of May 21, 2011. The contract was issued against Regenesis Biomedical's existing GSA Schedule 65-II-A for medical equipment and supplies, and did not utilize any...
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company, for the provision of the Provant Therapy System and related rental services. The $7,142.85 firm-fixed-price purchase order contract, awarded on February 2, 2011, with a completion date of March 2, 2011, was not set aside for any preference program. Regenesis Biomedical Inc. is the prime contractor and is providing its proprietary Provant...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc. for the company's Provant Therapy System, a non-invasive regenerative medicine product. The $7,055.10 firm fixed-price purchase order is for the supply and rental/leasing of the Provant Therapy System devices to VA medical facilities. This contract is under Regenesis Biomedical's existing General Services Administration (GSA) Schedule 65-II-A contract for medical equipment and supplies....
- This federal contract award was issued by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $4,820.98 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract has an ultimate completion date of January 20, 2011. Regenesis Biomedical has provided the Provant Therapy System and related rental...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $7,142.85 firm fixed-price purchase order contract is for the provision of Regenesis Biomedical's Provant Therapy System, a patented noninvasive regenerative medicine product indicated for the palliative treatment of post-operative pain and edema. The contract is not associated with any set-aside designations. Regenesis Biomedical,...
- This federal contract award was made by the Department of Veterans Affairs (VA) to Regenesis Biomedical Inc., a privately held medical technology company. The $3,645.14 firm fixed-price purchase order is for the Provant Therapy System, a noninvasive regenerative medicine product developed and patented by Regenesis Biomedical. The contract has an ultimate completion date of March 25, 2011. This award was made against Regenesis Biomedical's General Services Administration (GSA) Schedule 65-II-A...
- This federal contract award is for the Provant Therapy System, a proprietary medical device developed by Regenesis Biomedical Inc. The $7,203.90 firm fixed-price contract was awarded by the Department of Veterans Affairs (VA) through VA Integrated Service Network 17. The contract is for the supply and rental of the Provant Therapy System, which is indicated for the palliative treatment of post-operative pain and edema. The contract was awarded as a purchase order and is not associated with any...